Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Hims, Novo Nordisk and Hers Health
Hims & Hers Stock Rises on Earnings and Planned Generic Version of Novo Nordisk Diabetes Drug
Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo Nordisk’s diabetes drug as soon as 2025.It reported strong quarterly earnings. The stock rose 8.
Hims & Hers Health plans to offer generic version of Novo Nordisk's diabetes drug in 2025
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025. "We have already confirmed a core supplier for this addition and over the next few months expect to finish completing test and batch validation,
Hims & Hers Health plans to offer generic version of Novo Nordisk's drug
Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication kits at $79 per month
1d
on MSN
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating’
Shares of Hims & Hers Health Inc. rallied after hours on Monday after the wellness platform bumped its full-year sales ...
2h
Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Hims & Hers Health, Inc. investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beat ...
1d
Retired Newport News schools superintendent helps others with their next step — while finding hers
Ashby Kilgore was a bit apprehensive when she retired after 46 years in the public school system. “It was like, ‘What the ...
20h
Hims & Hers stock could dive soon despite strong results
Hims & Hers (HIMS) stock price remained on edge even after the fast-growing telehealth company published strong financial ...
6d
on MSN
A Juanes mega fan’s reaction to seeing him in the car next to hers goes viral
María Camila Zarta tells TODAY.com that as a Colombian immigrant seeing the singer felt like he gave her a piece of her ...
Seeking Alpha
1d
Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
Hims &
Hers
' strong Q3 results and 77% y/y revenue growth demonstrate its robust business, justifying a continued strong ...
1d
on MSN
Trump spends final rally hurling insults at enemies. Harris spends hers promising US ‘we’re not going back’
While Trump spent much of his nearly two-hour speech in Michigan ’s Grand Rapids hurling insults and profanities at his ...
6d
on MSN
"Martha" presents a side of Martha Stewart we haven't seen before: hers, in her voice
Martha Stewart is not big on sharing her feelings. To the millions who greedily gobbled up scuttlebutt about her legendary ...
1d
Hims & Hers Health: Another Blowout Quarter Ignored
Hims & Hers Health exceeded revenue expectations, achieved substantial subscriber growth, and remains undervalued in the ...
22h
Jonna Kim’s Buy Recommendation: Hims & Hers Health’s Robust Growth Trajectory and Market Potential
TD Cowen analyst Jonna Kim maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of ...
5d
Heidi Klum’s annual Halloween party is here! See all the 2024 costumes, including hers
Read on for updates about Heidi Klum's 2024 Halloween party including what she wore and other guests wore. Here are photos of ...
Stocktwits on MSN
1d
Hims & Hers Soars Pre-Market After Analysts Boost Price Targets On Strong Q3 Performance
Hims & Hers Health Inc. ($HIMS) rallied nearly 9% in pre-market trading on Tuesday, following the company’s third-quarter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
New York Stock Exchange
Hims
Trade
semaglutide
Novo Nordisk
Feedback